Geneoscopy co-founders Andrew Barnell, MBA, and Erica Barnell, M.D., Ph.D., have been named finalists for the Ernst & Young Entrepreneur Of The Year® 2025 Heartland Award, which honors leaders of high-growth, innovative companies in the Midwest. Under their leadership, St. Louis–based Geneoscopy has developed ColoSense®, an FDA-approved, non-invasive colorectal cancer screening test based on stool-derived RNA biomarkers, and is expanding its pipeline into inflammatory bowel disease diagnostics.
Keep Reading
Add A Comment